BioCentury | Dec 6, 2019
Targets & Mechanisms

Emerging immuno-oncology mechanisms at ASH 2019

...least three companies are targeting in the clinic, appears in five abstracts. A group from Technical University Munich...
...HSCT), which would be a new indication for a RIG-I agonist. The abstracts come from Technical University Munich...
...Senior Writer Inarigivir soproxil (sb 9200) American Society of Hematology Northwestern University University Health Network Kumamoto University Harvard Medical School University of Helsinki Technical University Munich Merck...
BioCentury | Jul 17, 2019
Preclinical News

July 17 Preclinical Quick Takes: Using CRISPR to edit TCRs, plus AAVs with synthetic promoters and AI for cancer diagnosis

...CRISPR can modify TCRs to reprogram T cells A Technical University Munich and Juno Therapeutics Inc. team led...
..."AI Code Could Speed Cancer Diagnosis" ). Mary Romeo, Assistant Editor Juno Therapeutics Inc. Memorial Sloan Kettering Cancer Center Technical University Munich Weill...
BioCentury | Jul 11, 2019
Distillery Therapeutics

Adoptive transfer with T cells expressing anti-HBV TCRs for HBV

...Protzer, Technical University Munich, Munich, Germany email: protzer@tum.de CONTACT: Karin Wisskirchen, same affiliation as above email: karin.wisskirchen@tum.de Claire Quang Technical University Munich Hepatitis...
BioCentury | Jun 11, 2019
Distillery Therapeutics

Inhibiting BCL10 or MALT1 for melanoma

...published online May 28, 2019 doi:10.1038/s41467-019-10203-2 CONTACT: Jürgen Ruland, Technical University Munich, Munich, Germany email: j.ruland@tum.de Claire Quang Technical University Munich B...
BioCentury | Jan 3, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2018

...side chains and binds SCTR with higher affinity than SCT, that could help treat obesity Technical University Munich...
BioCentury | Dec 12, 2018
Distillery Therapeutics

Endocrine/Metabolic

...published online Nov. 15, 2018 doi:10.1016/j.cell.2018.10.016 CONTACT: Martin Klingenspor, Technical University Munich, Munich, Germany email: mk@tum.de Mary Romeo Technical University Munich Obesity SCTR secretin secretin...
BioCentury | Nov 16, 2017
Preclinical News

Disease targets also act as tumor suppressors

...cell activation and increasing antitumor immunity. However, a study published in Nature from researchers at Technical University Munich...
...antisense inhibitor targeting glucagon receptor (GCGR). Allison Johnson idelalisib IONIS-GCCRRx IONIS-PTP1BRx Keytruda nivolumab Opdivo pembrolizumab Bristol-Myers Squibb Co. Gilead Sciences Inc. Ionis Pharmaceuticals Inc. Merck & Co. Inc. Technical University Munich University...
BioCentury | May 31, 2017
Distillery Therapeutics

Transplant

...et al. Sci. Transl. Med. ; published online April 19, 2017 doi:10.1126/scitranslmed.aag2513 CONTACT: Hendrik Poeck, Technical University Munich...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...in the top 75, while Germany has three: DKFZ, Ludwig Maximilians University of Munich and Technical University Munich...
...65 Swiss Federal Institute of Technology Lausanne (EPFL) 68 Ludwig Maximilians University of Munich 72 Technical University Munich...
...University, Stanford, Calif. SV Health Investors, Boston, Mass. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Technical University Munich...
BioCentury | Dec 20, 2016
Distillery Techniques

Assays and screens

...email: mmann@biochem.mpg.de CONTACT: Angela Krackhardt, Technical University of Munich, Munich, Germany email: angela.krackhardt@tum.de Karen Tkach Max Planck Society Technical University Munich Human...
Items per page:
1 - 10 of 58
BioCentury | Dec 6, 2019
Targets & Mechanisms

Emerging immuno-oncology mechanisms at ASH 2019

...least three companies are targeting in the clinic, appears in five abstracts. A group from Technical University Munich...
...HSCT), which would be a new indication for a RIG-I agonist. The abstracts come from Technical University Munich...
...Senior Writer Inarigivir soproxil (sb 9200) American Society of Hematology Northwestern University University Health Network Kumamoto University Harvard Medical School University of Helsinki Technical University Munich Merck...
BioCentury | Jul 17, 2019
Preclinical News

July 17 Preclinical Quick Takes: Using CRISPR to edit TCRs, plus AAVs with synthetic promoters and AI for cancer diagnosis

...CRISPR can modify TCRs to reprogram T cells A Technical University Munich and Juno Therapeutics Inc. team led...
..."AI Code Could Speed Cancer Diagnosis" ). Mary Romeo, Assistant Editor Juno Therapeutics Inc. Memorial Sloan Kettering Cancer Center Technical University Munich Weill...
BioCentury | Jul 11, 2019
Distillery Therapeutics

Adoptive transfer with T cells expressing anti-HBV TCRs for HBV

...Protzer, Technical University Munich, Munich, Germany email: protzer@tum.de CONTACT: Karin Wisskirchen, same affiliation as above email: karin.wisskirchen@tum.de Claire Quang Technical University Munich Hepatitis...
BioCentury | Jun 11, 2019
Distillery Therapeutics

Inhibiting BCL10 or MALT1 for melanoma

...published online May 28, 2019 doi:10.1038/s41467-019-10203-2 CONTACT: Jürgen Ruland, Technical University Munich, Munich, Germany email: j.ruland@tum.de Claire Quang Technical University Munich B...
BioCentury | Jan 3, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: December 2018

...side chains and binds SCTR with higher affinity than SCT, that could help treat obesity Technical University Munich...
BioCentury | Dec 12, 2018
Distillery Therapeutics

Endocrine/Metabolic

...published online Nov. 15, 2018 doi:10.1016/j.cell.2018.10.016 CONTACT: Martin Klingenspor, Technical University Munich, Munich, Germany email: mk@tum.de Mary Romeo Technical University Munich Obesity SCTR secretin secretin...
BioCentury | Nov 16, 2017
Preclinical News

Disease targets also act as tumor suppressors

...cell activation and increasing antitumor immunity. However, a study published in Nature from researchers at Technical University Munich...
...antisense inhibitor targeting glucagon receptor (GCGR). Allison Johnson idelalisib IONIS-GCCRRx IONIS-PTP1BRx Keytruda nivolumab Opdivo pembrolizumab Bristol-Myers Squibb Co. Gilead Sciences Inc. Ionis Pharmaceuticals Inc. Merck & Co. Inc. Technical University Munich University...
BioCentury | May 31, 2017
Distillery Therapeutics

Transplant

...et al. Sci. Transl. Med. ; published online April 19, 2017 doi:10.1126/scitranslmed.aag2513 CONTACT: Hendrik Poeck, Technical University Munich...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...in the top 75, while Germany has three: DKFZ, Ludwig Maximilians University of Munich and Technical University Munich...
...65 Swiss Federal Institute of Technology Lausanne (EPFL) 68 Ludwig Maximilians University of Munich 72 Technical University Munich...
...University, Stanford, Calif. SV Health Investors, Boston, Mass. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Technical University Munich...
BioCentury | Dec 20, 2016
Distillery Techniques

Assays and screens

...email: mmann@biochem.mpg.de CONTACT: Angela Krackhardt, Technical University of Munich, Munich, Germany email: angela.krackhardt@tum.de Karen Tkach Max Planck Society Technical University Munich Human...
Items per page:
1 - 10 of 58